About APHB

AmpliPhi Biosciences Corporation (APHB) is a biotechnology company focused on the development and commercialization of novel bacteriophage-based antibacterial therapeutics designed to target infections that are often resistant to existing antibiotic treatments. To advance its pipeline of bacteriophage-based therapies, AmpliPhi is collaborating with a number of leading organizations, including Intrexon Corporation (XON), the U.S. Army, The Royal Brompton Hospital in London, UK and UK-based University of Leicester.
Primary Exchange: AMEX
SIC Biological Products, (No Diagnostic Substances)
NAICS Biological Product (except Diagnostic) Manufacturing